Terry Yeung, DO
Otolaryngology · Denison, TXNPI 1902123698
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,955 of the $39,045 with a category attached, or 63.9%. Optinose US, Inc. accounts for 92.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $19,039 and has fallen 95.5% since, to $851 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $328.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$36K
- Stryker$3K
- Abbott$184
- Medtronic$96
- Acclarent, Inc$38
- Aerin Medical Inc.$33
- plus $162 from 8 others
What the payments were for
- Consulting fees$2,0005%
- Speaking & faculty fees$24,95564%
- Travel & lodging$8,19621%
- Food & beverage$3,89410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 75 | $35,993 |
| Stryker | 28 | $2,540 |
| Abbott | 2 | $184 |
| Medtronic | 3 | $96 |
| Acclarent, Inc | 1 | $38 |
| Aerin Medical Inc. | 1 | $33 |
| Intersect ENT, Inc. | 2 | $32 |
| Integra Lifesciences Corporation | 1 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| AstraZeneca | 1 | $19 |
| GSK | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Olympus America Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$35,001
- NA$2,450
- SCOPIS ENT$699
- SMARTLOCK$466
- ENTELLUS - XPRESS ENT DILATION SYSTEM$320
- PROCLAIM$158
- XPRESS ENT DILATION SYSTEM$128
How this compares
$39,045 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $1,373 |
| Ipratropium Bromide | 52 | $1,312 |
| Ofloxacin | 31 | $541 |
| Fluticasone Propionate | 41 | $460 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $321 |
| Cefdinir | 18 | $265 |
| Methylprednisolone | 14 | $112 |
| Amoxicillin | 25 | $76 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Denison
- Marc DeanFort Worth$486K
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ronald KuppersmithCollege Station$325K
- Ron KarniHouston$317K
- Philip ChenSan Antonio$305K
- Jordan RihaniSouthlake$280K
- Keith MathenyFrisco$269K
- Martin CitardiHouston$245K
- James AtkinsSan Antonio$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.